1. Home
  2. ULY vs CNSP Comparison

ULY vs CNSP Comparison

Compare ULY & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • CNSP
  • Stock Information
  • Founded
  • ULY 2013
  • CNSP 2017
  • Country
  • ULY United States
  • CNSP United States
  • Employees
  • ULY N/A
  • CNSP N/A
  • Industry
  • ULY
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • CNSP Health Care
  • Exchange
  • ULY Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • ULY 6.7M
  • CNSP 5.6M
  • IPO Year
  • ULY N/A
  • CNSP 2019
  • Fundamental
  • Price
  • ULY $4.87
  • CNSP $1.25
  • Analyst Decision
  • ULY Strong Buy
  • CNSP Hold
  • Analyst Count
  • ULY 1
  • CNSP 1
  • Target Price
  • ULY $12.00
  • CNSP N/A
  • AVG Volume (30 Days)
  • ULY 135.5K
  • CNSP 332.7K
  • Earning Date
  • ULY 05-12-2025
  • CNSP 05-14-2025
  • Dividend Yield
  • ULY N/A
  • CNSP N/A
  • EPS Growth
  • ULY N/A
  • CNSP N/A
  • EPS
  • ULY N/A
  • CNSP N/A
  • Revenue
  • ULY $142,905,000.00
  • CNSP N/A
  • Revenue This Year
  • ULY N/A
  • CNSP N/A
  • Revenue Next Year
  • ULY $17.87
  • CNSP N/A
  • P/E Ratio
  • ULY N/A
  • CNSP N/A
  • Revenue Growth
  • ULY N/A
  • CNSP N/A
  • 52 Week Low
  • ULY $2.99
  • CNSP $1.21
  • 52 Week High
  • ULY $32.04
  • CNSP $800.00
  • Technical
  • Relative Strength Index (RSI)
  • ULY 47.54
  • CNSP 30.28
  • Support Level
  • ULY $2.99
  • CNSP $1.28
  • Resistance Level
  • ULY $5.20
  • CNSP $1.46
  • Average True Range (ATR)
  • ULY 1.06
  • CNSP 0.38
  • MACD
  • ULY 0.09
  • CNSP -0.12
  • Stochastic Oscillator
  • ULY 45.30
  • CNSP 1.18

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: